1 | 75760 | Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. | Cancer | 1978 Feb |
1 |
2 | 121143 | [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)]. | Klin Wochenschr | 1979 Dec 3 |
1 |
3 | 469203 | [The value of cis-diamminedichloroplatinum (cis-platinum) CDDP in the treatment of stage III and IV cancers of the ovary (author's transl)]. | J Gynecol Obstet Biol Reprod (Paris) | 1979 Jan-Feb |
2 |
4 | 1281446 | The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. | Cancer Chemother Pharmacol | 1992 |
1 |
5 | 1282775 | [Successful management of choriocarcinoma of the testis with brain metastasis: a case report]. | Hinyokika Kiyo | 1992 Oct |
1 |
6 | 1286156 | Protein kinase C modulation. | Semin Cancer Biol | 1992 Dec |
1 |
7 | 1289495 | Disulfide bond cleavage of human fibrinogen by cis-diamminedichloroplatinum(II). | J Pharmacobiodyn | 1992 Nov |
6 |
8 | 1291340 | [A case of esophageal carcinoma with hypercalcemia caused by PTH-rP--the effect of therapy on the bone and calcium metabolism]. | Nihon Naibunpi Gakkai Zasshi | 1992 Dec 20 |
1 |
9 | 1306884 | Use of GM-CSF in children after high-dose chemotherapy. | Med Pediatr Oncol Suppl | 1992 |
1 |
10 | 1309303 | Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. | Cancer | 1992 Jan 1 |
1 |
11 | 1310490 | Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II). | Int J Cancer | 1992 Feb 1 |
4 |
12 | 1311914 | [Effect of lipiodol-cisplatinum arterial infusion chemotherapy on cellular immunity]. | Gan To Kagaku Ryoho | 1992 Mar |
1 |
13 | 1314712 | Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer. | Cancer Chemother Pharmacol | 1992 |
1 |
14 | 1314713 | The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278. | Cancer Chemother Pharmacol | 1992 |
2 |
15 | 1315778 | Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines. | J Cancer Res Clin Oncol | 1992 |
1 |
16 | 1316774 | A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines. | Br J Cancer | 1992 May |
1 |
17 | 1318287 | Cisplatin neuropathy in brain tumor chemotherapy. | Ital J Neurol Sci | 1992 May |
1 |
18 | 1319424 | A new, semi-automated system for the micro-scale synthesis of [195mPt]cisplatin suitable for clinical studies. | Int J Rad Appl Instrum A | 1992 Jun |
2 |
19 | 1321636 | Effects of cisplatin on human thyrocytes in monolayer or follicle culture. | J Mol Endocrinol | 1992 Jun |
3 |
20 | 1323213 | Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. | Am J Obstet Gynecol | 1992 Aug |
2 |
21 | 1323324 | Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: comparison of placebo vs. adrenocorticotropic hormone (ACTH). | Ann Oncol | 1992 Jun |
1 |
22 | 1323814 | Platinum/oral etoposide therapy in non-small cell lung cancer. | Oncology | 1992 |
1 |
23 | 1326318 | ACTH/MSH like peptides in the treatment of cisplatin neuropathy. | J Steroid Biochem Mol Biol | 1992 Sep |
4 |
24 | 1326334 | Inhibition of different steps of the ubiquitin system by cisplatin and aclarubicin. | Biochim Biophys Acta | 1992 Sep 15 |
7 |
25 | 1327513 | Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. | Cancer Res | 1992 Oct 15 |
4 |
26 | 1329216 | Clinical experiences with carboplatin (paraplatin) in lung cancer. | Semin Oncol | 1992 Feb |
2 |
27 | 1329884 | Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice. | Eur J Cancer | 1992 |
2 |
28 | 1330594 | Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F. | Eur J Pharmacol | 1992 Aug 6 |
1 |
29 | 1334113 | Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. | Int J Cell Cloning | 1992 Nov |
1 |
30 | 1345810 | Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin. | Cancer Res | 1992 Jan 15 |
6 |
31 | 1348364 | High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. | Proc Natl Acad Sci U S A | 1992 Apr 1 |
4 |
32 | 1350771 | [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy]. | Hokkaido Igaku Zasshi | 1992 Mar |
1 |
33 | 1353119 | Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. | J Urol | 1992 Aug |
1 |
34 | 1354671 | Restoration of proliferating cell nuclear antigen (PCNA) complex formation in xeroderma pigmentosum group A cells following cis-diamminedichloroplatinum (II)-treatment by cell fusion with normal cells. | J Cell Physiol | 1992 Sep |
10 |
35 | 1355663 | Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. | Br J Cancer | 1992 Sep |
2 |
36 | 1363120 | Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals. | J Pharmacobiodyn | 1992 Sep |
1 |
37 | 1370917 | Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy. | Cancer | 1992 Feb 15 |
2 |
38 | 1371415 | Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. | Blood | 1992 Mar 1 |
1 |
39 | 1372440 | Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. | Proc Natl Acad Sci U S A | 1992 Mar 15 |
2 |
40 | 1373636 | POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity. | Eur J Cancer | 1992 |
1 |
41 | 1374316 | Pharmacological agents affecting emesis. A review (Part I). | Drugs | 1992 Mar |
1 |
42 | 1377669 | The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma. | Jpn J Cancer Res | 1992 May |
9 |
43 | 1380075 | Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents. | J Pediatr Surg | 1992 Jun |
1 |
44 | 1380890 | Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. | Cancer Res | 1992 Sep 1 |
1 |
45 | 1381342 | Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens. | Jpn J Cancer Res | 1992 Jul |
1 |
46 | 1382047 | Reoxygenation in the RIF-1 tumor after chemotherapy. | Int J Radiat Oncol Biol Phys | 1992 |
1 |
47 | 1382255 | Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer. | Oncology | 1992 |
1 |
48 | 1384148 | Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. | Semin Oncol | 1992 Apr |
1 |
49 | 1384296 | [Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]. | Hinyokika Kiyo | 1992 Sep |
1 |
50 | 1384952 | Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity. | Cancer | 1992 Dec 1 |
1 |